Category Archives: The IPO Buzz

 

It looks like fast times in the IPO market these days. Since the beginning of March 2014, 58 companies filed to go public, 58 companies updated their filing plans, and 39 IPOs have been priced, according to the U.S. Securities and Exchange Commission filings. As impressive as these numbers are, today’s IPO calendar is not in a bubble mode. Actually, today’s traffic is BELOW the average for the last 34 years.

 

 

The good, the bad and the ugly all surfaced in last week’s IPO market. None were expected.

 

Fasten your seatbelts for a wild ride on the IPO highway. The technology sector is arriving. There is one deal on this week’s calendar plus three on next week’s; the filings continue to build, and their aftermarket performances are breathtaking.

 

 

The year’s first tech IPO popped with an opening-day moonshot, 2013’s last tech IPO lit up the sky with an opening-day starburst – and this week’s calendar features a tech IPO called Coupons.com.

 

There are only two deals on this week’s IPO calendar. Each has a message. One borrows from the wisdom of the racetrack. The other is a litmus test for what could be a wave of technology IPOs.

 

Last week’s traffic clearly signaled a shift in the trade winds sweeping through the Valley of IPOs. The cannonball run for the biotech sector looks like it’s over, but another sector is opening – technology.

 

 

Today’s “hot” IPO sector is starting to show signs of age. But if you listen to the wind, changes are in the works.

 

IPO players are ready to join the running of the biotechs through the canyons of Wall Street this week. Eleven of the 14 IPOs that are on the calendar are biotechs. And last week’s traffic was dominated by – yes – biotechs. Four of the eight IPOs that were priced were from this sector. A couple scored opening-day moonshots.